Ariane Hallermayr
Head of Research and Development, MGZ – Medical Genetics Center
Ariane Hallermayr is listed as Head of Research and Development, MGZ – Medical Genetics Center. Ariane is scheduled to speak at MEDICA 2026 on 18 November 2026.
Compiled from published conference agendas; not yet confirmed by Ariane. Is this you? Claim this profile.
About
As Head of Research & Development at the MGZ – Medical Genetics Center in Munich, Ariane Hallermayr develops diagnostic approaches based on circulating free DNA. Her research covers ctDNA applications in oncology and mosaic disorders, untargeted methods such as cfDNA fragmentomics, and the standardization needed for routine clinical use. She is a Visiting Scientist at LMU University Hospital, Co-Lead of the Regulatory Working Group of the European Liquid Biopsy Society, and received the MUG Dissertation Award in 2025.
Upcoming
MEDICA 2026 16 November 2026 – 19 November 2026
- Case of the Day: Precision Diagnostics - Biomarkers. Innovation. Impact. Speaker · 18 November 2026
- Circulating Biomarker – The Next Generation of Precision Diagnostics Speaker · 18 November 2026
- Reverse Panel: Precision Diagnostics - Biomarkers. Innovation. Impact. Speaker · 18 November 2026
Spoke alongside
People who have shared a session with Ariane at events on B2DB.
- Verena Haselmann Professor of Translational Precision Diagnostics · Universitätsklinikum Hamburg-Eppendorf 3 shared sessions
- Björn Nowack Managing Director · SensID GmbH 2 shared sessions
- Maximilian Christopeit Attending Physician · University Medical Center Hamburg-Eppendorf 2 shared sessions
- Nils Große Hokamp Senior Managing Radiologist · University Hospital of Cologne 2 shared sessions